Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: A pilot study

Current Medical Research and Opinion

Volumn 26, Issue 1, 2010, Pages 37-40

  Voltolini, Susanna ^a   Troise, Costantino ^a   Incorvaia, Cristoforo ^b   Bignardi, Donatella ^a   Di Cara, Giuseppe ^c   Marcucci, Francesco ^c   La Grutta, Stefania ^d   Frati, Franco ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b ICP Hospital   (Italy)

^c Surgical Specialties and Public Health ^*  (Italy)

^d CNR   (Italy)

^e Medical and Scientific Department   (Italy)

Author keywords

Allergic asthma; Allergic rhinitis; Birch pollen; Sublingual immunotherapy

Indexed keywords

CETIRIZINE; DESLORATADINE; FLUTICASONE PROPIONATE; FORMOTEROL; LORATADINE; PLACEBO; STALLERGEN; STALLERGENES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BIRCH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MALE; NOSE OBSTRUCTION; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINORRHEA; SEASONAL VARIATION; SUBLINGUAL IMMUNOTHERAPY; DRUG ADMINISTRATION ROUTE; IMMUNOTHERAPY; MIDDLE AGED; PILOT STUDY; SEASON;

ADULT; ASTHMA; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PILOT PROJECTS; PLACEBOS; SEASONS;

EID: 77649206445     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903431886     Document Type: Article

References (11)

1. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-48 (Pubitemid 36337857)
2. Wilson DR, Torres-Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
3. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-8 (Pubitemid 44272577)
4. Penagos M, Passalacqua G, Compalati E, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133:599-609 (Pubitemid 351367366)
5. Calamita Z, Saconato H, Pelá AB, et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162-72 (Pubitemid 44326350)
6. Global Initiative on Asthma (GINA) International Guidelines. Update 2007. Available at: www.ginasthma.org [Last accessed 6 February 2008]
7. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma -Summary report 2007. J Allergy Clin Immunol 2008;120:S94-138
8. Bousquet J, Van Cauwenberge P. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001;108:S1-315
9. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003 (4):CD001186
10. Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double blind, double dummy study. Allergy 2004;59: 45-53 (Pubitemid 38167951)
11. Mauro M, Russello M, Incorvaia C, et al. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Allergy Clin Immunol 2007; 39:119-22